Publishers have long worried that artificial intelligence would drive readers away from their sites. They’re about to find out if those fears are warranted.
OpenAI and the FDA are reportedly discussing AI for drug evaluations
- today, 5:09 PM
- techcrunch.com
- 0
No comments